VMD: Explanation for business results in quarter 2/2012

Vimedimex Medi-Pharma Joint Stock Company (VIMEDIMEX) has explained revenue and profit in quarter 2/2012 as follows:

-         Net revenue decreased 47.70% (VND729.48 billion) and cost of goods sold decreased 48.03% (VND721.34 billion).

-         Gross profit decreased 29.55% (VND8.14 billion) and net profit decreased 18.30% (VND1.28 billion) leading profit before tax in quarter 1/2012 decreased VND1.22 billion (17.35%) compared with in quarter 2/2011 and profit after tax in quarter 2/2012 decreased VND0.93 billion (15.04%) compared with in quarter 2/2011.

HOSE

>   CMG: Explanation for parent company’s business result in Q2/2012 (30/07/2012)

>   CTI: Explanation for business result in Q2/2012 (30/07/2012)

>   GSP: Explanation for business results in Q2/2012 (30/07/2012)

>   AGR: Explanation for business result in Quarter 2/2012 (30/07/2012)

>   HDG: Explanation for business result in Quarter 2/2012 (30/07/2012)

>   MBS: Explanation for business results in Q2/2012 (30/07/2012)

>   MCP: Explanation for business result in Q2/2012 (30/07/2012)

>   MTG: Explanation for business results in Q2/2012 (30/07/2012)

>   VNSC: VNSC changes a address of Head Office (30/07/2012)

>   SDA: Financial Statement Quarter 2_2012 (30/07/2012)